Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy - PubMed (original) (raw)
doi: 10.1016/j.nut.2005.06.003.
Maria Rita Lusso, Clelia Madeddu, Elena Massa, Roberto Serpe, Laura Deiana, Giovanna Lamonica, Mariele Dessì, Carla Spiga, Giorgio Astara, Antonio Macciò, Giovanni Mantovani
Affiliations
- PMID: 16459226
- DOI: 10.1016/j.nut.2005.06.003
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy
Giulia Gramignano et al. Nutrition. 2006 Feb.
Abstract
Objective: Fatigue is a multidimensional symptom that is described in terms of perceived energy, mental capacity, and psychological status: it can impair daily functioning and lead to negative effects on quality of life. It is one of the most common side effects of chemotherapy and radiotherapy. In recent studies, l-carnitine (LC) supplementation has been demonstrated to be able to improve fatigue symptoms in patients with cancer.
Methods: In the present study we tested the efficacy and safety of LC supplementation in a population of patients who had advanced cancer and developed fatigue, high blood levels of reactive oxygen species, or both. As outcome measures we evaluated fatigue and quality of life in relation to oxidative stress, nutritional status, and laboratory variables, mainly levels of reactive oxygen species, glutathione peroxidase, and proinflammatory cytokines. From March to July 2004, 12 patients who had advanced tumors (50% at stage IV) at different sites were enrolled (male-to-female ratio 2:10, mean age 60 y, range 42-73). Patients were only slightly anemic (hemoglobin 10.9 g/dL) and hemoglobin levels did not change after treatment. LC was administered orally at 6 g/d for 4 wk. All patients underwent antineoplastic treatment during LC supplementation.
Results: Fatigue, as measured by the Multidimensional Fatigue Symptom Inventory-Short Form, decreased significantly, particularly for the General and Physical scales, and for quality of life in each subscale of quality of life in relation to oxidative stress. Nutritional variables (lean body mass and appetite) increased significantly after LC supplementation. Levels of reactive oxygen species decreased and glutathione peroxidase increased but not significantly. Proinflammatory cytokines did not change significantly.
Conclusion: Improvement of symptoms with respect to fatigue and quality of life in relation to oxidative stress may be explained mainly by an increase in lean body mass, which may be considered the most important nutritional or functional parameter in assessing the cachectic state of patients. In this view, fatigue with related symptoms can well be considered an important constituent of cancer-related anorexia cachexia syndrome.
Similar articles
- Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, Dessì M, Tanca FM, Sanna E, Deiana L, Panzone F, Contu P, Floris C. Mantovani G, et al. Nutrition. 2008 Apr;24(4):305-13. doi: 10.1016/j.nut.2007.12.010. Epub 2008 Feb 11. Nutrition. 2008. PMID: 18262758 Clinical Trial. - Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
Mantovani G, Madeddu C, Macciò A, Gramignano G, Lusso MR, Massa E, Astara G, Serpe R. Mantovani G, et al. Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1651-9. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15466983 Clinical Trial. - L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
Ciacci C, Peluso G, Iannoni E, Siniscalchi M, Iovino P, Rispo A, Tortora R, Bucci C, Zingone F, Margarucci S, Calvani M. Ciacci C, et al. Dig Liver Dis. 2007 Oct;39(10):922-8. doi: 10.1016/j.dld.2007.06.013. Epub 2007 Aug 10. Dig Liver Dis. 2007. PMID: 17693145 Clinical Trial. - Antimyopathic effects of carnitine and nicotine.
Laviano A, Meguid MM, Guijarro A, Muscaritoli M, Cascino A, Preziosa I, Molfino A, Rossi Fanelli F. Laviano A, et al. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):442-8. doi: 10.1097/01.mco.0000232905.89662.60. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778574 Review. - Menopause: a review on the role of oxygen stress and favorable effects of dietary antioxidants.
Miquel J, Ramírez-Boscá A, Ramírez-Bosca JV, Alperi JD. Miquel J, et al. Arch Gerontol Geriatr. 2006 May-Jun;42(3):289-306. doi: 10.1016/j.archger.2005.08.005. Epub 2006 Jan 26. Arch Gerontol Geriatr. 2006. PMID: 16442644 Review.
Cited by
- Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia.
Pradhan R, Dieterich W, Natarajan A, Schwappacher R, Reljic D, Herrmann HJ, Neurath MF, Zopf Y. Pradhan R, et al. Cancers (Basel). 2024 May 18;16(10):1921. doi: 10.3390/cancers16101921. Cancers (Basel). 2024. PMID: 38791998 Free PMC article. Review. - The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review.
Bel'skaya LV, Gundyrev IA, Solomatin DV. Bel'skaya LV, et al. Curr Issues Mol Biol. 2023 Sep 13;45(9):7513-7537. doi: 10.3390/cimb45090474. Curr Issues Mol Biol. 2023. PMID: 37754258 Free PMC article. Review. - A Review of Nutraceuticals in Cancer Cachexia.
Caeiro L, Gandhay D, Anderson LJ, Garcia JM. Caeiro L, et al. Cancers (Basel). 2023 Jul 30;15(15):3884. doi: 10.3390/cancers15153884. Cancers (Basel). 2023. PMID: 37568700 Free PMC article. Review. - Nutrient Therapy for the Improvement of Fatigue Symptoms.
Barnish M, Sheikh M, Scholey A. Barnish M, et al. Nutrients. 2023 Apr 30;15(9):2154. doi: 10.3390/nu15092154. Nutrients. 2023. PMID: 37432282 Free PMC article. Review. - Targeting Skeletal Muscle Dysfunction With L-Carnitine for the Treatment of Patients With Chronic Obstructive Pulmonary Disease.
Hoang BX, Han BO, Fang WH, Nguyen AK, Shaw DG, Hoang C, Tran HD. Hoang BX, et al. In Vivo. 2023 Jul-Aug;37(4):1399-1411. doi: 10.21873/invivo.13224. In Vivo. 2023. PMID: 37369514 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials